Studies have also shown that the expression of TLR4 are higher in non-small cell lung cancers (NSCLC) than that in normal tissues and the expression of its serum soluble pattern may act as a biomarker to predict radiation pneumonia risk in local advanced NSCLC patients [99, 100]. The gene discussed is TLR4; the disease is non-small cell lung carcinoma.